606 related articles for article (PubMed ID: 26454036)
1. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
2. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
4. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Lee JJ; Cheng SL; Chen HM; Chang HH; Wang YP; Kok SH; Kuo MY; Chiang CP
Oral Oncol; 2012 May; 48(5):424-8. PubMed ID: 22244591
[TBL] [Abstract][Full Text] [Related]
5. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
Zhang W; Gao C; Zhang S; Fang G
J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534
[TBL] [Abstract][Full Text] [Related]
6. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
7. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
[TBL] [Abstract][Full Text] [Related]
8. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
9. Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer.
Lin CW; Tseng SW; Yang SF; Ko CP; Lin CH; Wei LH; Chien MH; Hsieh YS
Oral Dis; 2012 Nov; 18(8):734-40. PubMed ID: 22533572
[TBL] [Abstract][Full Text] [Related]
10. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
11. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
12. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis.
Pu Y; Wang L; Wu H; Feng Z; Wang Y; Guo C
Oncol Rep; 2014 Jun; 31(6):2644-50. PubMed ID: 24700287
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma.
Ma HL; Yu C; Liu Y; Tan YR; Qiao JK; Yang X; Wang LZ; Li J; Chen Q; Chen FX; Zhang ZY; Zhong LP
J Oral Pathol Med; 2015 Mar; 44(3):193-200. PubMed ID: 25047743
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
Zhou JH; Zhang B; Kernstine KH; Zhong L
World J Gastroenterol; 2011 Mar; 17(10):1373-8. PubMed ID: 21455340
[TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma.
Sedighi M; Aledavood SA; Abbaszadegan M; Memar B; Montazer M; Rajabian M; Gholamin M
Asian Pac J Cancer Prev; 2016; 17(6):2781-5. PubMed ID: 27356690
[TBL] [Abstract][Full Text] [Related]
18. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
[TBL] [Abstract][Full Text] [Related]
19. Correlation of increased twist with lymph node metastasis in patients with oral squamous cell carcinoma.
Wushou A; Pan HY; Liu W; Tian Z; Wang LZ; Shali S; Zhang ZY
J Oral Maxillofac Surg; 2012 Jun; 70(6):1473-9. PubMed ID: 21864967
[TBL] [Abstract][Full Text] [Related]
20. Expression of αvβ6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications.
Li HX; Zheng JH; Fan HX; Li HP; Gao ZX; Chen D
J Oral Pathol Med; 2013 Aug; 42(7):547-56. PubMed ID: 23331428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
